{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T09:37:17Z","timestamp":1786441037711,"version":"build-2736575974"},"reference-count":26,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: To determine whether continuous glucose monitoring (CGM)-derived metrics can differentiate between normoglycemia, increased diabetes risk (FINDRISC+) and prediabetes and to assess whether CGM-derived metrics provide additional discriminatory information beyond conventional laboratory markers. Materials and Methods: In this cross-sectional study, 41 adults without diabetes were classified as normoglycemic controls (HbA1c &lt; 5.7%, FINDRISC &lt; 12), individuals at increased diabetes risk (HbA1c &lt; 5.7%, FINDRISC \u2265 12), or individuals with prediabetes (HbA1c 5.7\u20136.49%). All participants underwent 14-day CGM. Mean interstitial glucose, glycemic variability (SD, CV) and time in, above and below range (TIR, TAR, TBR) were analyzed. Group differences were assessed using ANOVA or non-parametric tests; correlations were evaluated using Pearson analysis. Results: HbA1c differed significantly across groups (F = 17.62; p &lt; 0.001). Among CGM metrics, only mean interstitial glucose differed (F = 3.54; p = 0.039), driven by higher values in the prediabetes group. Glycemic variability and time-based metrics did not differ significantly. Substantial overlap was observed between the increased risk and prediabetes groups. No significant correlation was found between HbA1c and mean CGM glucose (r = 0.164; p = 0.30). Conclusions: In this exploratory cohort, short-term CGM-derived metrics provided limited additional discriminatory information beyond conventional laboratory markers and clinical risk assessment. Larger prospective studies are needed to determine the discriminatory and predictive value of CGM in early metabolic risk states.<\/jats:p>","DOI":"10.3390\/medicina62081539","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T08:09:36Z","timestamp":1786435776000},"page":"1539","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Limited Discriminatory Capacity of Continuous Glucose Monitoring in Prediabetes and Increased Diabetes Risk: A Cross-Sectional Study"],"prefix":"10.3390","volume":"62","author":[{"given":"D\u00f3ra Marietta","family":"Balogh","sequence":"first","affiliation":[{"name":"Department of Internal Medicine and Oncology, Semmelweis University, Kor\u00e1nyi S\u00e1ndor u. 2\/a., 1083 Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karola","family":"Osgy\u00e1n","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Oncology, Semmelweis University, Kor\u00e1nyi S\u00e1ndor u. 2\/a., 1083 Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdolna","family":"B\u00e9keffy","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Oncology, Semmelweis University, Kor\u00e1nyi S\u00e1ndor u. 2\/a., 1083 Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikl\u00f3s","family":"Kempler","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Haematology, Semmelweis University, Szentkir\u00e1lyi u. 46., 1088 Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gergely","family":"Balaton","sequence":"additional","affiliation":[{"name":"Department of Paediatric Dentistry and Orthodontics, Semmelweis University, Szentkir\u00e1lyi u. 47., 1088 Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9549-8504","authenticated-orcid":false,"given":"Manfredi","family":"Rizzo","sequence":"additional","affiliation":[{"name":"School of Medicine, ProMISE Department, University of Palermo, 90133 Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7888-2651","authenticated-orcid":false,"given":"Viktor J\u00f3zsef","family":"Horv\u00e1th","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Oncology, Semmelweis University, Kor\u00e1nyi S\u00e1ndor u. 2\/a., 1083 Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e9ter","family":"Kempler","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Oncology, Semmelweis University, Kor\u00e1nyi S\u00e1ndor u. 2\/a., 1083 Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8613-2341","authenticated-orcid":false,"given":"Adrienn","family":"Menyh\u00e1rt","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Oncology, Semmelweis University, Kor\u00e1nyi S\u00e1ndor u. 2\/a., 1083 Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1001\/jama.2023.4063","article-title":"Diagnosis and Management of Prediabetes: A Review","volume":"329","author":"Perreault","year":"2023","journal-title":"JAMA"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/2047487319880041","article-title":"Risk and management of pre-diabetes","volume":"26","author":"Beulens","year":"2019","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1080\/03007995.2019.1601455","article-title":"Understanding prediabetes: Definition, prevalence, burden and treatment options for an emerging disease","volume":"35","author":"Rett","year":"2019","journal-title":"Curr. Med. Res. Opin."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"725","DOI":"10.2337\/diacare.26.3.725","article-title":"The diabetes risk score: A practical tool to predict type 2 diabetes risk","volume":"26","author":"Tuomilehto","year":"2003","journal-title":"Diabetes Care"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Fizelova, M., Jauhiainen, R., Stan\u010d\u00e1kov\u00e1, A., Kuusisto, J., and Laakso, M. (2016). Finnish Diabetes Risk Score Is Associated with Impaired Insulin Secretion and Insulin Sensitivity, Drug-Treated Hypertension and Cardiovascular Disease: A Follow-Up Study of the METSIM Cohort. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0166584"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S2213-8587(13)70103-7","article-title":"Non-invasive risk scores for prediction of type 2 diabetes (EPIC-InterAct): A validation of existing models","volume":"2","author":"Abbasi","year":"2014","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S2213-8587(22)00319-9","article-title":"Continuous glucose monitoring and metrics for clinical trials: An international consensus statement","volume":"11","author":"Battelino","year":"2023","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1177\/19322968221123530","article-title":"Difference on Glucose Profile from Continuous Glucose Monitoring in People with Prediabetes vs. Normoglycemic Individuals: A Matched-Pair Analysis","volume":"18","author":"Rizos","year":"2024","journal-title":"J. Diabetes Sci. Technol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1089\/dia.2024.0226","article-title":"From Stability to Variability: Classification of Healthy Individuals, Prediabetes, and Type 2 Diabetes Using Glycemic Variability Indices from Continuous Glucose Monitoring Data","volume":"27","author":"Cichosz","year":"2025","journal-title":"Diabetes Technol. Ther."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e3002","DOI":"10.1002\/dmrr.3002","article-title":"New insights from continuous glucose monitoring into the route to diabetes","volume":"34","author":"Colas","year":"2018","journal-title":"Diabetes Metab. Res. Rev."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"112286","DOI":"10.1016\/j.diabres.2025.112286","article-title":"Diabetes risk assessment in adult population without diabetes employing continuous glucose monitoring: A novel approach","volume":"226","author":"Izquierdo","year":"2025","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1089\/dia.2023.0468","article-title":"Accuracy and Safety of the 15-Day CareSens Air Continuous Glucose Monitoring System","volume":"26","author":"Kim","year":"2024","journal-title":"Diabetes Technol. Ther."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2337\/dci19-0028","article-title":"Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations from the International Consensus on Time in Range","volume":"42","author":"Battelino","year":"2019","journal-title":"Diabetes Care"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.2337\/dc18-1581","article-title":"Glucose Management Indicator (GMI): A New Term for Estimating A1C from Continuous Glucose Monitoring","volume":"41","author":"Bergenstal","year":"2018","journal-title":"Diabetes Care"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Rama Chandran, S., Sng, G.G.R., Wong, C.Y.H., Ang, W.M., and Gardner, D. (2025). Continuous Glucose Monitoring Metrics in Asians Without Diabetes: Differentiating Prediabetes From Normoglycemia. J. Diabetes Sci. Technol., 19322968251384682.","DOI":"10.1177\/19322968251384682"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.diabres.2010.12.020","article-title":"Evaluation of the Finnish Diabetes Risk Score as a screening tool for impaired fasting glucose, impaired glucose tolerance and undetected diabetes","volume":"92","author":"Tankova","year":"2011","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Arnard\u00f3ttir, E., Sigur\u00f0ard\u00f3ttir, \u00c1.K., Graue, M., Kolltveit, B.H., and Skinner, T. (2023). Using HbA1c measurements and the Finnish Diabetes Risk Score to identify undiagnosed individuals and those at risk of diabetes in primary care. BMC Public Health, 23.","DOI":"10.1186\/s12889-023-15122-y"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1210\/jc.2010-0012","article-title":"Identification of undiagnosed type 2 diabetic individuals by the Finnish Diabetes Risk Score and biochemical and genetic markers: A population-based study of 7232 Finnish men","volume":"95","author":"Wang","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/dom.14638","article-title":"Understanding the clinical implications of differences between glucose management indicator and glycated haemoglobin","volume":"24","author":"Choudhary","year":"2022","journal-title":"Diabetes Obes. Metab."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"460","DOI":"10.2337\/dc23-1177","article-title":"Estimating Glycemia from HbA1c and CGM: Analysis of Accuracy and Sources of Discrepancy","volume":"47","author":"Tozzo","year":"2024","journal-title":"Diabetes Care"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Professional Practice Committee (2026). 6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes\u20142026. Diabetes Care, 49, S132\u2013S149.","DOI":"10.2337\/dc26-S006"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1001\/jama.2025.19197","article-title":"Continuous Glucose Monitoring","volume":"334","author":"Bergenstal","year":"2025","journal-title":"JAMA"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1111\/dme.14065","article-title":"Associations between HbA(1c) and continuous glucose monitoring-derived glycaemic variables","volume":"36","author":"Hirsch","year":"2019","journal-title":"Diabet. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1177\/15209156251379506","article-title":"Lack of Association Between Hemoglobin A1c and Continuous Glucose Monitor Metrics Among Individuals with Prediabetes and Normoglycemia","volume":"28","author":"Rodriguez","year":"2025","journal-title":"Diabetes Technol. Ther."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"118","DOI":"10.2337\/dc25-1811","article-title":"Association of Age at Type 2 Diabetes Onset with Diabetes Progression","volume":"49","author":"Sajjadi","year":"2026","journal-title":"Diabetes Care"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Professional Practice Committee for Diabetes (2026). 7. Diabetes Technology: Standards of Care in Diabetes\u20142026. Diabetes Care, 49, S150\u2013S165.","DOI":"10.2337\/dc26-S007"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/8\/1539\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T09:11:35Z","timestamp":1786439495000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/8\/1539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,11]]},"references-count":26,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["medicina62081539"],"URL":"https:\/\/doi.org\/10.3390\/medicina62081539","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,11]]}}}